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This paper investigates and reviews literature regarding a range of topics important to the research 
question – the themes apply across all the topics. The topics include label and package warnings, 
including tamper-evident features, to review their effect on the consumer behaviour of changing 
usage or purchase decisions. This information was then applied to gain insight into anticounterfeit 
product/package efforts. Based on this research, it appears that there is value for brand marketers 
to enhance their anticounterfeit efforts and consumer confidence by utilizing warning labels and 
information labels on their labels or packages. Currently, consumer perception of a domestic 
counterfeit product threat (promoted as genuine products), even for pharmaceuticals by healthcare 
professionals, although increasing has still been very low. Generally, the consumers believe and 
expect that the product purchased from retailers is safe and genuine. The study reviewed many 
key warning and label communication areas: consumer behaviour review, technical specifications, 
anticounterfeit, tamper evidence/tamper resistance, over-the-counter drugs, alcohol, cigarette, 
nutrition food and nutrition supplements. To complete the insight on communicating with the 
consumer, a review of label legibility was included. Before brand marketers consider adding 
anticounterfeit warning labels, extensive consumer behaviour research should be conducted in 
areas such as fear appeals and involuntary risk outrage.  
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INTRODUCTION 
There is great attention, financial spending, confusion and lack of scholarly research on applying 
solutions to the rising counterfeit product problem. It is estimated that US businesses lose $200 
billion annually to counterfeiting and that 10% of the cosmetics and toiletries worldwide are 
counterfeit.1 In addition, the legal concept of ‘foreseeable hazard’ seems to be increasing in 
corporate risk management awareness. If sold by weight, producing and distributing fake CD or 
DVDs are five times more profitable than selling illegal drugs.1 These acts of producing counterfeit 
or fraudulent products and packages constitute an illegal activity under most national laws 
regulating commerce and trade. 
Although there has been a great deal of research in both consumer behaviour influences of warning 
statements and technical package label specifications, there is limited scientific work specifically 
integrating and meshing both study areas. A systems approach where no single component works 
alone has been effectively used in many product groups, for example in tamper evidence (TE) and 
tamper resistance (TR). Further developments are occurring in the anticounterfeit strategy systems 
approach as mass serialization (unique product code for every product) and auto-identification use of 
sophisticated barcodes and radio frequency identification (RFID) mature. Many global corporations 
today coordinate functional groups of corporate security, packaging, intellectual property law, brand 
management and supply chain management. Various studies have shown the impact of RFID and 
improved tracking and traceability in a wide range of products including apparel, consumer goods, 
health and beauty aids and fresh produce (fruits and vegetables) in a global marketplace that often 
wants brand-name products to reduce risk of fake, fraudulent, adulterated or counterfeit products.2 
However, limited research or activity has been conducted in considering warning labels as an 
anticounterfeit measure. 
This research reviewed various sources of literature regarding label and package warnings, 
including tamper-evident features, to review their effect on the consumer behaviour of changing 
usage or purchase decision. The focus was on the concept of the package/product counterfeit 
threat. This research focuses on the consumers who are intending, and expecting, to buy genuine 
product. Reviewing or proposing anticounterfeit packaging component features as well as 
reviewing intellectual property rights or copyright issues or warnings is beyond the scope of this 
research. 
There are many disparate themes and topics that assist in choosing the most effective and 
efficient countermeasure. This research project was structured to review the applicable concepts 
one at a time, which is also consistent with the previous published research that is focused by 
topic. 
• Themes 
o Package, label and consumer behaviour 
o Labels, warnings and content communication 
o Anticounterfeit package components and labels 
o Tamper-evident and tamper-resistant components and labels 
• Specific topics 
o Over-the-counter (OTC) medications, components and labels 
o Alcohol warning labels 
o Cigarette labelling, warnings 




This research project provides insight based on evidence available in academic research studies. 
The research focused on various published papers in journals, which are shown in Table 1. This 
research reviewed specific publications and gave preference to refereed, peer-reviewed journals 
with supporting news articles or trade publication articles, where supporting information was 
important. 
The research project begins with a review of several key themes including package, label and 
consumer behaviour; labels, warnings and content communication; anticounterfeit package 
components and labels; and tamper-evident and tamper-resistant components and labels. Several 
specific topics will be reviewed in the following section. 
Package, label and consumer behaviour 
Packaging systems include labels, package features based on size and shape, primary package, outer 
package, overwrap (such as tamper-evident sleeve), pricing or promotional material, shipping 
container and palletized product. The following excerpts are from findings of several previous 
research studies. 
A variety of individual different variables affect whether or not someone notices, encodes, comprehends, and complies 
with a warning.3  
As the US population grows older, an emerging complication will be age-related with challenging perceptual and 
cognitive abilities.3  
A warning label ignored is not effective.4 
 
[Insert Table 1] 
Many warning labels are the result of legal or regulatory requirements. Warnings are 
intended to prevent mishaps such as injury, illness or damage to property. It is assumed that 
if properly warned against a hazard, consumers are less likely to have adverse incidents 
with a product. Some who study warnings, however, question whether this is really the 
case. Research conducted by the Failure Analysis Associates, California, USA, suggests 
that ‘a warning is unlikely to change behavior if a person fails to read or understand it, or is 
unmotivated or unable to change’.5,6 
A critical risk communication concept is how consumers actually process information. 
General consumer behaviour research states that consumers frequently employ two to three 
key points when making a purchase decision and have difficulty comprehending or coping 
with a risk that eliminates the warning as one of those decision factors. To increase the 
effectiveness of warnings, multiple information mediums should be used. 
The optimum labeling system is an information provision system with 4 components: 1. point-of-
purchase displays, 2. advertisements, 3. labels and 4. package inserts.7 
Further review of various studies concludes that ‘product type’ actually has a low 
correlation to the attention a warning label receives, and ‘vividness-enhancing 
characteristics’ and warning location were more significant features. The dimensions that 
were studied were attention, reading and comprehension, recall, judgment and behavioural 
compliance.8 There is even evidence that reading warning labels differs for males and 
females, including variations in adolescent and adults of each sex. The variation is due to 
differences in socialization gender traits that carry over to the underlying propensity to use 
product labels.9 
The consumer cognitive (thinking versus feeling) biases are important to consider because 
‘harms of omission over harms of direct action’ conflict with the need to deal with many 
risks at once (multiple risks in one product or among products purchased in the entire buying 
trip), and the multiple risks can conflict and lead to an error in estimation of the magnitude 
or probability of risk.10 
The ability for consumers to make comparisons between products is crucial, which includes price marks (price 
sticker), active ingredients and quantity, dosage, and the like.11 
Consumers truncate information searches to just the information on the front of labels, and 
those who truncated the messages associated a ‘halo effect’ (‘rating the product higher on other 
health attributes not mentioned in the clam’) or a ‘magic bullet’ attribute (attributing 
inappropriate health benefits to the product).12 The same was witnessed for environmental claims 
such as ‘ozone-free’.13 
It was of interest to review the response to nutrition label regulations and how they are justified 
and understood.12 
• Consumers are unable to understand nutrition information on the package (e.g. the nutrition 
facts panel). 
• Even if consumers can understand the nutrition facts panel, in practice, they ignore it and 
instead rely only on the health claim. 
• When both sources of information are read, the presence of a health claim alters how 
consumers weigh nutrition information from different parts of the package in such a way that 
incorrect nutritional inferences are made about the product. 
Addressing risks, but de-emphasizing them in relation to the benefits, can lead to selective retrieval 
and possibly re-interpreting evidence in light of advertising (consider erectile dysfunction ads where 
half the ad is an attractive scene with a voice-over mentioning a long list of warnings and risks that are 
numerous and warned as potentially very severe). The research found that when customers have actual 
physical experience with the product, the ad helps recall of those physical experiences. When 
consumers do not have experience with a product, the ads were the context in which consumer 
behaviour was engaged. In essence, when consumers did not have personal experience with a product, 
the ad was the product experience. 
Overall, the experiments suggested that consumers do not need very convincing evidence before they begin to 
believe advertising claims.14 
The issues of believability of a warning are also crucial to the label’s effectiveness, and a key 
feature is ‘probabilistic versus definite’ statements on the labels,15 for example, ‘warning – 
smoking has been linked to lung cancer’ versus ‘warning – poison – induce vomiting if 
swallowed’. 
There are predictions that consumer use of nutrition labels is increasing. The familiarity and 
experience in understanding the warning information in one product group will equate to 
expertise in interpreting label information in other more complex or even lower-involvement 
product groups.16 
Labels, warnings and content communication 
Extensive research on OTC pharmaceutical warning label text and wording specification has 
been conducted at the Michigan State University School of Packaging.17 This research clearly 
supports a performance standard versus the ‘prescriptive’ approach pursued by the US Food and 
Drug Administration (FDA). The research used proprietary equipment that determined that font 
style is as important a factor as font size, where a 5.5-point font typeface (FDA minimum, 6-
point font) was more legible than a much larger 9-point font FDA-compliant design.17,18 In 
addition, some font styles are more effective than others, and it focused on legibility in low-light 
situations to simulate the environment or other physical eyesight limitations.19 Verdana was 
found to be a more legible font style than Gills Sans or Univers Ultra Condensed (Figure 1).18 
Regarding label text content, too much information can lead the low-involvement consumer to 
skip reading or understanding and interpreting the label. A recent study indicated that optimal 
message communication is provided when a short claim on the front of a package was provided 
and more detailed instructions were available elsewhere on the outer package.20 In addition, 
warning labels with simple words were easier to read and more efficiently understood by subjects 
with a wide range of education level – 50% of US adults have sixth-grade or lower reading 
levels21 – common and clear signal words are critical22 and, when they actually read the warning 
labels, consumers were able to generally determine risks quickly and accurately.23 Additional 
research emphasizes a need for warnings in several languages and other strategies for ‘special 
needs’ populations.24 Research revealed that consumer label information preferences vary 
widely.25 
[Insert Figure 1] 
In other research, contrary to the hypothesis, ‘familiar’ word messages were not unequivocally 
‘easier’ for the subjects to read. This continues to support the elementary consumer behaviour 
theory that ‘uninvolved consumers are less likely to seek information’ because it is plausible that 
the commonly used English language phrases are not ‘familiar’ to consumers in the warning 
label context.17 In other words, the finding supports the idea that consumers are not (regularly) 
reading OTC labels. Further adding to the complexity of the issue, other research revealed that 
retailer-applied price tags and security antitheft tags were frequently applied over the FDA-
regulated ‘drug facts box’ (50.4%), specifically over the warning (23.6%) and the active 
ingredients (9.3%) and product use (4.4%) text.26 The security tags were considered necessary to 
prevent pilferage because it is estimated that OTC medications are the most pilfered drugstore 
items.26 
A summary of key warning label components are noted: 
• ‘Signal word: A single, attention-getting word (e.g., “Warning!”) should appear at the head of 
the warning in large type size as an indicator that the label contains important information’15,22 
• ‘Hazard statement: A single statement should identify the nature of each relevant hazard’15 
• ‘Consequences: The warning should describe the resulting outcomes of ignoring the 
hazard(s)’15 
• ‘Instructions: The warning should specify the behaviors that may result in injury or damage (i.e., 
how to avoid the hazard). The warning should also describe appropriate remedial or emergency 
treatment’15 
Anticounterfeit package components and labels 
The state-of-the-art anticounterfeit actions are centred on applying multiple layers of tamper-
evident and hard-to-reproduce anticounterfeit packaging features such as colour-shifting inks, 
holographic stickers, holograms with wireless tracking devices,27 reverse-printed tamper-evident 
shrink bands, nano-coatings that can only be detected by proprietary or laboratory equipment, 
layers of micro-laser printing, micro-laser etching and so on.28,29 To help consumers self-
authenticate product, the tobacco industry has used tear tapes and advanced film wrapping for 
years. Leading pharmaceutical companies have discussed many initiatives for package 
components, for track-and-trace authentication throughout the distribution and supply chain 
networks and for central databases to verify lot and product codes. Emerging markets such as 
India and China are flooded with counterfeits in some product groups with as much as 15% to 
50%. Suppliers of products such as printer cartridges have developed programs where consumers 
can check lot and product codes on the brand owner’s company website.29 A key observation 
regarding anticounterfeit package features or labels for pharmaceuticals or other products is that 
they do not utilize warning labels for either the risk of counterfeit products or directions on how to 
authenticate the product. Although consumer groups and product manufacturers highly 
recommend processes for consumers to authenticate suspect products, there is an absence or 
limited information or warning labels on packages.29 
Tamper-evident and tamper-resistant components and labels 
The most studied and active area of security packaging is in TE and TR. Before covering the 
warning label aspect, it is important to establish a review of the root features and objectives of 
the packaging components. The goal of TE is for the consumer to notice ‘evidence’ that the 
package has been tampered with. The goal of TR is to make tampering more difficult.30 In 1994, 
the FDA regulated that pharmaceutical products be tamper-evident, not just tamper-resistant. 
Consumers are now aware of potential product tampering, which makes package durability, to 
not look tampered after routine handling, a package requirement.31 In addition, the tamper-
evident features of the product on the shelf must be noticeable by the consumer. An induction-
sealed bottle (a sealed membrane over the bottle opening, then the cap is placed over that 
membrane) does not indicate TE until the consumer opens the cap. In that instance, if the 
membrane is removed with no residue, a consumer might not realize that a tamper-evident 
feature was even supposed to be there. 
Extensive work has been conducted in tamper-evident/tamper-resistant and child-resistant (CR) 
packaging for the past 20 years at the Michigan State University School of Packaging.32 This 
research focused on packaging components of shrink band, membrane seal, plastic overwrap, 
blister package and vacuum button. ‘Successful tamper evidence requires consumer education, 
packages that are easy for consumers to diagnose, a limited variety of systems, a reduction rate of 
package change, better instructions for use.’33 Even with state-of-the-art packaging components 
and procedures, research found that 12% to 50% of consumers were unable to detect tampering.34 
In addition, ‘consumers were largely unaware of the tamper resistant statements now mandatory 
on pharmaceutical products’.34 It is important to investigate root causes for consumers’ perception 
that a package was or was not tampered because common misconceptions have been 
experienced.35 
The amount of security required to ‘resist’ tampering depends on the objective to thwart the 
casual or malicious tamperer.36 A ‘casual’ tamperer is a consumer who only wants to taste the 
peanut butter before buying, and a ‘malicious’ tamperer is one whose intent is to inflict harm. 
There is forensic value to the tamper-evident features because a tampered package can be studied 
to evaluate the level of sophistication of the tamperer and to estimate where in the supply chain the 
tampering occurred. For instance, a 1986 New York Times article, regarding the Tylenol 
poisonings referred to forensic evidence that led them to believe that the product was tampered 
with after it left the manufacturer.37 Four years earlier, in 1982, the industry experienced a 
tampering scare with the Dristan product, where a tampered capsule was sent to the NY City 
Health Department.38 An additional prevention step can be for brand marketers to engage 
packaging professionals to evaluate TR and TE and to provide an overview across the product line 
or to understand opportunities with new packaging features.38 
Research still emphasizes a need for greater TR as well as ‘improved signaling of tampering to the 
consumer’.39 As early as 1988, the marketing community started understanding the risks 
surrounding malicious tampering events.40 The major difference between recent and historical 
package tampering is the scope of potential harm. Faced with the possibility of mass consumer 
poisonings, marketers should develop preventive programmes to forestall criminal intervention. 
Strict liability is the dominant legal theory when consumers have been injured, but negligence 
liability is the primary approach available.40 A single tampering incident or scare can change 
package designs instantly. In 1991, a Sudafed capsule tampering resulted in mass questioning of the 
package form of capsules and a rapid retail preference for non-openable doses.41 Another example 
of a response from a scare is that after the 2005 baby food ‘ricin’ poisoning, many baby food 
manufacturers added a second tamper-evident/tamper-resistant feature of the shrink band (the first 
tamper-evident feature was the vacuum ‘pop’ lid). 
To provide additional insight and cover some well-researched applications, the research project 
reviews several key topics including Over-the-counter medication components and labels; 
Alcohol warning labels; Cigarette labelling, warnings; and Nutrition – food labelling. Many 
specific food examples are included because of the extent of the research on this specific label 
warning communication and marketing. 
Over-the-counter medication components and labels 
Additional research has found that 1.94 million hospital admissions per year are due to drug non-
compliance [Bix L. 2000, Michigan State University, East Lansing, Michigan, USA, unpublished 
data]. For an OTC drug label’s message to be successfully delivered, consumers must notice it, 
encode it, comprehend it and comply with it. Failure at any of the stages of consumer/label 
interaction reduces message effectiveness. The four steps of this process have been studied 
extensively in recent years because of many societal changes already presented. Although the 
knowledge base is substantial with regard to this topic, it is still lacking. No single model or 
format indicates what facilitates focal attention, successful encoding, complete information 
processing, elaborate comprehension and compliance in elderly consumers, and many findings 
contradict one another [Bix L. 2000, Michigan State University, East Lansing, Michigan, USA, 
unpublished data]. 
The FDA is focusing regulation on improving the legibility of OTC drugs by specifying design 
elements of the labels. For example, legibility research went further and developed equipment and a 
procedure to quantify the legibility of various printing fonts. Legibility of OTC labels is of particular 
significance because it is a major factor in allowing products to be switched from a prescription to 
OTC classification, which usually has a much higher volume.42 Another study quantified misuse and 
even ‘off‐ label recreational’ use by teenage consumers.43 The goal of the recreational use was 
similar to illicit drug use to ‘get high’ or ‘get drunk faster’.43 A retail audit found that although the 
font size of the brand name and key features and benefits increased with package size, the warnings 
and indication still remained the same font size.26 Print size has been a common theme for 
significantly improving the information acquisition of OTC labels.44 ‘No substantial effects on 
knowledge acquisition performance from the white space manipulations [area around the words, 
within a warning text box] were found’, although larger print and its associated additional white 
space did exhibit the maximum information acquisition.44 
Alcohol warning labels 
A 1‐year and 5‐year study of alcohol warning label effects on 10th and 12th graders determined 
that an ‘initial novelty of the warning labels appears to have led to some initial positive 
effects’.45 ‘The novelty of the warning label however, appears to have worn off [at 3.5 years after 
exposure]’.45 Because the ‘Alcohol Beverage Labeling Act’ went into effect in 1989, most of the 
research has focused on short‐term effects of the warnings.46 The study investigated by directly 
asking ‘How Effective Are Alcohol Warning Labels?’ The answer was that not only does the 
impact of the warning wane after introduction, but ‘those with a favorable attitude toward 
alcohol consumption tend to disbelieve specific instance warnings’.46 Regarding the efficacy of 
alcohol warning labels and messages, evidence suggests that their effectiveness is limited to low 
awareness or knowledge gain and little or no changes in the perceived risks associated with 
alcohol use, let alone changes in attitudes or behaviours. This may be because people already 
know the content of warning labels and messages, become desensitized after hearing repeatedly 
about the risks associated with alcohol use or fail to find the information personally relevant.46 
Consumers seem to be more aware and act on warning labels when their health condition or status 
changes, such as becoming pregnant.47,48 A very significant research project explored the 
‘Noticeability of Warnings on Alcohol Beverage Containers’.49 Noticeability of warning 
information is important because if a warning is not seen, it cannot realistically have any effect on 
its target audience. The quality or efficacy of a warning’s content is irrelevant if the warning is 
never noticed or read. The results of this experiment show that various design parameters of actual 
alcohol container warnings influence the noticeability of the mandated warning. The variables 
having the greatest influence were the subjective measures: noticeability of the warning, 
noticeability of the government warning and label clutter. The warnings considered to be less 
noticeable (noticeability of the warning) were those that had shorter signal word length and greater 
clutter on the labels. The warnings that had a less noticeable signal word (noticeability of the 
government warning) were those that had a shorter signal word length and fewer lines. Also, the 
containers that were considered more ‘busy’ or ‘cluttered’ were those that had fewer labels on 
which to place information and a smaller area (in square inches) for the warning.49 
Another researcher found that ‘cognitive responses (rational thought responses, not feelings) in 
diagnosing the persuasive effectiveness of the warning label’ have been under‐considered.48,50 The 
process of the consumer forming counter‐arguments is critical to the warning’s effectiveness, once 
the consumer is persuaded to actually read the warning. Also, initial attitudes towards consumption 
of the product played a key role in a consumer’s believability of the warning. The message itself 
carried 70%  more ‘thought’ of the warning, as compared with the source of authority (e.g. 
Surgeon General).48 A key proposed insight from this study was to rotate various warnings to try 
to capture the attention of the consumer. In 2006, this concept of rotating marketing slogans or 
labels is employed by several food and beverage companies (e.g. Heinz Ketchup name, Molson 
Canadian beer back label, Taco Bell comments on salsa packets). Similar research findings 
applied to warnings on print and television advertisements, package label warnings51 and wall 
posters.52 
Cigarette labelling, warnings 
In 1964, the US Surgeon General reported a link between cigarette tar and lung cancer, and then 
in 1966, the Federal Trade Commission encouraged cigarette companies to note their tar levels 
on the package labels.53 A dramatic market share shift occurred where cigarettes with ≤15 mg of 
tar grew from 0% in 1960 to 68% in 1992 (pre-1960, the average cigarette had 37 mg of tar). 
Although the labelling and research led to far lower average levels of tar, ‘In a 1980 Roper 
survey, 36% of smokers thought that their low-tar cigarette did not significantly increase a 
smoker’s risk of disease over that of nonsmokers, and another 31% were not sure if this was the 
case’.53 
In addition, cigarette industry documents speak to this issue: ‘We have evidence of virtually no 
quitting among smokers of those brands, and there are indications that the advent of ultra low tar 
cigarettes has actually retained some potential quitters in the cigarette market by offering them a 
viable alternative.’53 Research of teen smokers concluded that ‘starker, briefer and more direct 
messages’ (e.g. ‘Smoking Can Kill You’) were enhanced by a plain white package versus putting 
them within the copy of a full label. More ‘technical, longer and vaguer’ messages did not increase 
effectiveness.54 Graphic and vivid warning labels were effective, leading to 20% of the study 
participants smoking less (1% reported smoking more). The negative emotions were not considered 
psychologically extreme.55 
Nutrition – food labelling 
Health claims. ‘Healthy’ is a term that has inspired reams of scholarly research and is a package 
label content term originally regarded as ‘true’, but now consumers are desensitized to the 
unique value of a ‘healthy’ product.56 Consumer research has indicated that nutritional label 
reading is only a small part of a consumer’s total search criteria,57 although the underlying trend 
is that nutritional food labels have statistically significantly increased the healthy eating patterns 
of Americans.58 
A health claim characterizes the relationship between a food nutrient and the risk of a disease or health-related 
condition.59 These claims can alert consumers to a product’s health potential by stating that certain foods – as 
part of an overall diet – may reduce the risk of certain diseases.60 Such efforts, however, are not always 
successful.20,59–63 
Congress passed the Nutritional Labeling and Education Act in 1990. This Act regulated 
‘healthy’ claims for total fat, saturated fat, cholesterol or sodium versus specified limits. In 
addition, the total ‘healthy’ value of a product must be followed, for example where a product 
low in fat but high in sodium cannot make healthy claims.64 
Product labels are the consumer’s primary means of receiving information about nutritional or 
health claims. Consumers also receive nutritional and health information from point-of-purchase 
displays, educational campaigns, as well as from personal contact. It was found that consumers 
can be sceptical of new health claims, so the public sector (academia, government agencies, 
public health communities and the medical field) has a key role in lending credibility to new 
claims.63 Consumers are very unlikely to recognize ‘incongruences’ between claims or nutrient 
levels of one additive in comparison with another additive, as well as cumulative claims on the 
‘healthy’ essence of a food.65 
It is felt that the nutritional label regulation is justified by considering the following:64 
• First, consumers may lack the competence to comprehend nutrition information on the 
product label (i.e. they may not understand whether 8 g of fat in a product is low or high). 
• Second, health claims may influence consumers’ processing of nutrition information on the 
product label even if they have the ability to understand nutrition information. 
• Third, consumers may decide to rely solely on the health claim and ignore the nutrition 
information altogether. 
The amount of consumer involvement with the product does seem to play a role in seeking and 
understanding information labels. In a study of initial introduction of air-tight, vacuum-packed 
fresh beef, consumers overcame the concern regarding the unusual brownish-red colour of the 
beef for the higher-involvement, more expensive meats such as fillet mignon.66 
Health claims are most influential when the consumer is aware of nutritional properties or 
attributes (vitamin A content or level of saturated fat) and knowledge of how these attributes 
affect health (vitamin A is good for eyesight, low saturated fat is good for controlling 
cholesterol).63 It does appear that the location of the information is important because consumers 
trust health claims made on a label and are more sceptical of claims in advertisements.48 
‘Additive‐free’ labelling. Research found several product groups where the ‘additive-free’ phrase 
(cholesterol-free, etc.) has led consumers to believe a product is more healthy, for example 
stating a vegetable oil has ‘no cholesterol’ is actually true of the entire vegetable oil category, but 
the single brand established a marketing competitive advantage.67 
Overall, the results suggest that displaying common but previously neglected attributes has 
both brand-level and product-level category effects. At the brand level, studies suggest that using 
the narrow ‘cholesterol-free’ tag on brand labels results in the following: 
• Feature-absent inferences (if the attribute of ‘additive-free’ is not mentioned, this brand must 
not have it) about those brands that do not mention the attribute 
• Choices in favour of brands displaying the attribute 
• Increased accessibility of the target attribute for those subjects who believe that the target 
attribute is atypical in the product category 
These results support the FDA position that this type of ‘nutrient-free’ claim appears to 
mislead consumers in a narrow product category definition context. Therefore, the FDA ruling 
that disallows the practice of using this type of ‘free’ nutrient claim on foods that are inherently 
free of the nutrient can benefit consumers in those contexts.68 Other studies suggest that broader 
‘nutrient-free’ claims are less deceptive and help inform low-knowledge consumers regarding 
the typicality of the nutritional attribute for all brands in the product category.68 
That being said, few product-level groups use the ‘nutrient-free’ claims.68 Because the brand 
marketers cannot use the ‘nutrient-free’ claim as a point of differentiation, if every company in a 
product-level group used the claim, it would be a point of parity and a waste of precious 
advertising space on the package label. 
New additives or processing. The packaging trade press has discussed the situation where 
warning label regulations can raise concerns when, scientifically, none are present. For example, 
labelling of ‘organic’ or ‘bovine somatotropin (bST)-free foods’ can lead consumers to believe 
that non-organic or bST-containing foods are scientifically significantly inferior.6 The same was 
noted for irradiated foods, scientifically safe levels of pesticide residues, bioengineered foods 
and also acrylamide found in fried foods like French fries.6 
Examples. Bovine somatotropin or bovine growth hormone. (Note: Bovine growth hormone is 
referred to as bST, rbST, BGH or rbGH.)69,70 An example of the Nutrition Labeling and 
Education Act (21 U.S.C. 301) is a ban on stating ‘BGH-free’, where the science-based risk is 
still in question and the statement of BGH-free may create a risk perception where no risk may 
be present.71 
Negative labeling [an alternate phrase for “nutrient/additive-free” discussed above] of traditional foods (e.g., 
milk is claimed “from cows not treated with rBST”) should be discouraged. Such labeling implies the food has 
a special attribute which which it does not have. Negative labeling may mislead and confuse consumers, and 
provides no additional public health protection. It is predicted that the label statement of “GMO-free” would 
lead consumers to perceive a risk, or at least a warning.67 
Regarding bST, the results of consumer behaviour studies found that different personal 
situation characteristics ‘correlated with different levels of awareness, risk perceptions and self-
protective actions’.72 Specifically identified were characteristics of hereditary health history, 
ethnicity, educational level, sense of control over their lives and identification with 
environmental groups.72 In addition, the study finds a correlation with consumers who identify 
with environmental groups as being more self-protective against the use of bST or other ‘non-
natural’ products. This concept may be a marketing tool for the environmental product 
manufacturers. The study also found that consumers ‘responsible for the health of others’ 
(typically the primary grocery shopper for their children) demonstrated a higher motivation to 
avoid the bST product.72 
The study confirms the complex ‘multifaceted nature of consumer risk behavior.’ Also, ‘that 
there are not only separate stages of risk perceptions associated with different levels of 
awareness and action but also that different factors seem to influence these stages and, as such, it 
is possible to predict what stages consumers might be in by their characteristics’.72 
Margarine. During the initial market growth of margarine, the dairy industry lobbied not only 
for prohibiting yellow white margarine but also for trying to mandate the use of non-customary 
butter colours of pink, red and black. In this case, the dairy industry tried to use these ‘negative 
attribute’ to their marketing advantage as a source of initially unacceptable consumer 
preference.67 
Saccharin warning labels. The effect of saccharin warning labels on consumer behaviour was 
reviewed for the soft drink category (75+% of the US saccharin sales). Although sales initially 
slowed in some consumer sub-segments, the warning labels had no apparent effect on overall 
sales. ‘While the sales of saccharin-containing products did not decrease overall, the warning 
may have been a success in informing the public of a risk and then letting consumers make 
more informed decisions’.73 
Genetically modified foods and organisms. For genetically modified foods and organisms 
(GMO), the negative-labelling/nutrient-free statement of ‘GMO-free’ has led to concerns from 
the users of GMO products. ‘A label that discloses the use of genetic engineering techniques can 
add significantly to the product costs of certain foods, particularly processed foods that are 
produced from pooled fresh fruits and vegetables’.67 
In 2002, Oregon did not pass Measure 27, which required labels for genetically modified 
foods. A complex series of concerns surrounded the vote, but an underlying trend was that 
consumers did have (realized they had) a concern for what was in the food they were eating.74 
Essentially, choosing staple foods like breakfast cereal, milk, tomatoes and potatoes was elevated 
from a low-involvement/lowknowledge to a high-involvement purchase/high-knowledge 
purchase. 
Interestingly, some manufacturers who utilize genetically modified foods or organisms are 
steering away from using the common ‘GMO’ acronym and are using ‘GM’.75 The GM acronym 
may be less associated with ‘genetically modified’, and in a low-involvement/low-knowledge 
situation, consumers may be confused by the icon ‘General Motor’s’ very recognized abbreviation 
GM. 
Nutrition, supplements. The Dietary Supplement Health and Education Act went into effect in 
1994, and it created the class of products known as ‘supplements’ – neither food nor drug. The 
Dietary Supplement Health and Education Act allows supplement manufacturers to ‘use structure 
function claims, such as, “Helps promote a healthy emotional balance,” on supplement package 
labels without premarket FDA approval, provided the legislative disclaimer is included’.75 This 
right to state such claims was upheld by the courts citing the first amendment free-speech 
protection.75,76 
A 2005 study of ‘supplements’ in the Journal of Consumer Affairs pursues many consumer 
behaviour concepts that can be applied to a wide range of products:75 
• Preliminary research suggests that priming consumers to pay particular attention to certain 
aspects of a product label can significantly influence use and understanding of the label. 
• Consumers do not discern between ‘structure–function claims’ (e.g. helps maintain 
cardiovascular function) and ‘disease claims’ (e.g. prevents development of malignant 
tumours). 
• Consumers did respond to ‘express disease claims’ (e.g. for prevention of osteoporosis). 
• Consumers with high involvement for health or disease prevention had a higher degree of 
belief in the function and disease claims than those with low involvement. 
The key finding was that consumer’s existing and distantly related beliefs can override product 
or label information. On the positive side, some consumers may try effective innovative 
products, and on the negative side, some consumers ‘may eliminate a potentially helpful product 
from their evoked set [the set of choice alternatives activated directly from memory]’.75,77 
DISCUSSION 
The purpose of this research was to examine open-source literature regarding label and package 
warnings, to review their effect on the consumer behaviour or changing usage or purchase 
decisions and to apply the insights to the package/product counterfeit threat. The research found 
that consumers do not generally read warning labels. Within regulations, brand marketers place 
negative risks or warnings in ways that minimize the impact on the consumer’s purchase decision. 
Print and media advertisements utilize the selective retrieval of information quite effectively. 
Brand marketers also know, and leverage, the findings that consumers truncate searches on front 
labels to the detail on the back labels – consumers either rated the effectiveness higher or the risk 
lower than stated in the claims. In addition, consumers often associated the ‘magic bullet’ effect – 
where a consumer attributes other, not stated, benefits to the product. The issue of believability of 
warning labels is crucial to helping consumers avoid injury of a potentially dangerous, if misused, 
product. Specifically noted for alcohol warning labels, the message itself carried more weight than 
the endorser, even when the endorser was the Surgeon General. For a warning label to be effective, 
consumers must first notice a label, then read it, then comprehend it and then recall the instructions 
during future uses (when they may not read the label). There is evidence that alcohol warning 
labels are effective when first implemented but that the impact wanes over time. Although the 
research does state that consumers are more aware of warning labels as their health status changes, 
for example, becoming pregnant or as health deteriorates, more direct and harsher messages were 
most effective – e.g. ‘Smoking Can Kill You.’ 
The nutrition ‘additive-free’ claims have very interesting consumer behaviour consequences that 
can be applied to other product groups. It was clearly defended that previously non-highlighted 
product attributes (e.g. ‘Zero Trans Fats’, ‘Whole Grains’) did bring new positive attention to the 
product. At the same time, ‘GMO-free’ (without genetically modified foods and organisms) claims 
created a consumer awareness of the concept and a perception that if GMO-free was a good 
feature, products that did not say GMO-free were more risky or significantly inferior. The nutrition 
supplement marketers are successfully using structure–function claims (‘helps promote a healthy 
emotional balance’) to the point that consumers do not discern between these and direct disease 
claims (‘prevents skin cancer’). Also important is that consumers with high-involvement interests 
in health claims or disease prevention tended to have a higher level of belief in the claims than 
those with low involvement. 
The research also found many ways to communicate the information and risks effectively to 
the consumer. 
Technical and structural packaging and label overview 
Label specifications such as font style and font size are key to readability of warnings. Research 
found that the ‘Verdana’ font style is superior for warning and information text. In addition, for 
the many low-involvement/low-information products, an appropriate balance of emphasizing the 
warning must be reached to communicate risks but not overwhelm the consumer to the point that 
they ignore the warning. Clearly, uninvolved consumers are less likely to read the warnings, and 
generally, the research supports that consumers do not read even OTC drug warning labels. Clear 
signal words and warning images are critical, as are clearly differentiated text – many alcohol 
warnings meet regulations but are hard to find on the packages. In addition, more common 
warning text/phrases across all product groups may lead consumers to recognize the phrases in 
the context of warnings. A series of ‘special needs’ should be considered, such as the visual 
acuity of the ageing population and warnings in several common languages. 
Anticounterfeit warning label applications 
Based on this research, it appears that there is value for brand marketers to enhance their 
anticounterfeit efforts by utilizing warning labels and information labels. A key is focusing on the 
consumers who are intending, and expecting, to buy a genuine product. Currently, consumer 
perception of a domestic counterfeit product threat, even for pharmaceuticals by healthcare 
professionals, is increasing but still very low. Generally, consumers believe that a product from 
their retailer is safe and genuine. Current anticounterfeit efforts by brand marketers are focused on 
strengthening the control of the supply chain and in adding multiple complex layers of 
anticounterfeit packaging features. For package labels, there is no evidence that brand marketers 
are including counterfeit warnings or processes to authenticate the product. Brand marketers do 
sometimes reference the ability to authenticate product on their websites or in direct contact with 
large business-to-business customers. 
Many of the anticounterfeit multiple-layered packaging features are coordinated or included 
with other features, such as with tamper-evident packaging components (e.g. anticounterfeit 
complex printing on a typical tamper-evident shrink band). For specific high-counterfeit-risk 
products, the multi-purpose feature is very cost effective and also very complex, which adds 
additional barriers for the counterfeiter trying to copy the package or product. 
Although return on investment is still not clear, there are many questions about harmonization 
and standardization of systems, and there are very real concerns about security assurance of the 
codes, and consumer products appear to be leading towards a mass-serialization concept where 
every single package has its own unique product code. This mass-serialization concept will be 
critical to enabling the automatic-identification RFID initiatives specified by the US FDA. 
From an international perspective on general standards, in 2009, the International Standards 
Organization (ISO) addressed the product counterfeit threat by forming the Technical Committee 
247 Fraud Countermeasures and Controls. The first step in 2009 was to create Product 
Committee 246 Authentication tools, which are slated to become ISO Standard 12931. The next 
action item is to develop an international standard for Security Assurance for the Document and 
Product Security Industry [based on the American National Standards Institute (the US 
international standards body) and the North American Security Products Organization, 
ANSI/NASPO-SA-2008]. ISO TC 247 is also developing a report to harmonize the terminology. 
Specifically, for food ingredients, the US Pharmacopoeia joined with the Food Chemicals 
Codex and created the Food Ingredient Intentional Adulteration Expert Panel. For the potential 
impurities in counterfeit or fraudulent product, the organization is developing overviews 
(Chapters), reference test specimens (Reference Standards) and technical specifications 
(monographs). 
With some of the mass-serialization coding schemes, advanced application algorithms are applied 
to a 26-field alpha-numeric codes, which makes it ‘impossibly difficult’ for a counterfeiter to guess 
any series of even two codes. The only legitimate codes the counterfeiter could determine are codes 
read off legitimate product (if the codes are laser etched or two-dimensional matrixes, the technical 
counterfeiter could determine the genuine ‘code’). If both genuine and counterfeit codes were 
authenticated, the database, and thus the consumer, would be alerted that one of the two products 
was a fake. 
The mass-serialized codes would allow and possibly motivate consumers to authenticate their 
product; in addition, widespread authentication of product would help the brand marketers in 
their investigations against bogus product. Multiple data points of validation and quick 
identification of rouge product would be helpful. Brand marketers and retailers are working very 
hard to tighten the control of their supply chains, but the huge profitability of the occasional 
elusive hit-and-run nature of product counterfeiting fuels its continued growth. 
CONCLUSION 
Based on this research, it appears that there is value for brand marketers to enhance their 
anticounterfeit efforts by utilizing warning labels and information labels. An anticounterfeit warning 
label could communicate to the consumer that there is a risk of counterfeit product and that they 
should register or authenticate their product. To maintain clarity, it is recommended to stick with 
structure–function claims (e.g. ‘helps promote a healthy emotional balance’) versus direct disease 
claims (e.g. ‘prevents skin cancer’). That being said, critical pharmaceutical products do have 
options to effectively use direct disease claims (e.g. ‘WARNING: Fake Heart Medicine Exists, 
Immediately Authenticate Your Product. See Your Pharmacist or product.com/authenticate’). A 
conceptual example is included Figure 2. 
The counter-argument that counterfeiters would just not put the warnings on their 
counterfeited product so the warnings do not get to the affected consumer does not hold up. The 
majority of consumers are trying to, and expecting to, buy genuine product through a legitimate 
channel. For a counterfeiter who is focused on infiltrating the genuine supply chain with either 
stolen or occasional products to not be detected, the package and labels would need to be exact, 
including the anticounterfeit warning. That being said, the counterfeiters have been known to 
fake authentication website links. Brand marketers have systems in place to monitor package and 
label authenticity, and the teams include international and US customs and international and US 
investigators, in addition to internal product testing protocols. 
[Insert Figure 2] 
There is a very real danger that the new anticounterfeit warnings could inadvertently bring 
negative publicity or negative consumer perception to the brand or product or to even create an 
inherent fear of the brand or the product. But with care and understanding of warnings and 
information labels from other product groups, there is a high likelihood that the anticounterfeit 
warning labels would be effective and even be leveraged to increase brand trust. A key will be giving 
the consumer a process to immediately satisfy their curiosity or fear – a way to authenticate. The 
anticounterfeit warnings have a real possibility of creating competitive advantages and consumer 
goodwill, as the nutrient‐free claims have attained. 
An objective will be to give the consumer incentive to continue to (or automatically) 
authenticate and not have the impact of the label wane to the point where consumers have had so 
many ‘positive’ confirmations that they perceive a very low risk and stop authenticating the 
product. 
Access to authenticate the codes is required, but this also creates a fraud opportunity if the 
counterfeiters can covertly gather legitimate codes. The counterfeiters could then use those 
harvested legitimate codes to apply to counterfeit packages. For example, a non‐line‐of‐sight 
system, such as RFID, that allows retailers and distributors to identify and check codes also 
provides the counterfeiters with the fraud opportunity to harvest those same genuine codes. To 
assure availability and security, it may be necessary to develop separate serialized codes for 
consumers and retailers. 
LIMITATIONS 
This research did not study the effect of pre‐cautionary and warning labels that are required by law 
for products and packaging for chemicals, hazardous materials, flammable, poisons, etc. Such 
warning and labelling information has been covered in various national and international 
regulatory agencies.78 
In addition, before brand marketers consider adding anticounterfeit warning labels, extensive 
consumer behaviour research should be conducted in areas such as fear appeals and involuntary 
risk outrage.79,80 In addition, serious consideration to the potential responses and risks posed by 
counterfeiters must be reviewed [Spink and Moyer, 2011, Michigan State University, East 
Lansing, Michigan, USA, unpublished data]. In addition, the economic impact of the full 
additional costs associated with implementing and managing mass serialization and 
automatic‐identification innovations should be followed to review how and when anticounterfeit 
warning labels will benefit the safety and security of the consumers without deteriorating 
brand‐recognized product sales. 
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